Chronic News and Research

RSS

Manchester researchers launch new project to better understand causes of RA

Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.

27 Jun 2013

Ind., Ark. Medicaid expansion plans take shape, but also take time

Also, news outlets examine the idea that the expansion's new enrollees will likely be healthier than current beneficiaries but this will probably not relieve the expansion's pressure on the health care workforce.

27 Jun 2013

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys AG and Celgene Corporation today announced an agreement to jointly develop MOR202 globally and to co-promote MOR202 in Europe.

27 Jun 2013

BHS takes initiative to improve health and wellness of Berkshire community with CRI

Berkshire Health Systems today announced an initiative to improve the health and wellness of the Berkshire community with its new partner, the non-profit Canyon Ranch Institute.

27 Jun 2013

Physician’s unfavorable attitudes about opioid drugs linked with lower rates of prescribing

According to a study of physicians' attitudes about pain drugs published in The Journal of Pain, negative physician attitudes about opioid medications are closely associated with lower rates of prescribing and more favorable attitudes are linked with higher prescribing levels.

26 Jun 2013

Eisai submits BELVIQ NDS with Health Canada

Arena Pharmaceuticals, Inc. announced today that Eisai Limited (based in Mississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission for BELVIQ (lorcaserin HCl) with Health Canada.

26 Jun 2013

Improving care for depression in low-income communities provides greater benefits: Study

Improving care for depression in low-income communities -- places where such help is frequently unavailable or hard to find -- provides greater benefits to those in need when community groups such as churches and even barber shops help lead the planning process, according to a new study.

26 Jun 2013

Study explores analgesic activity of ceftriaxone in humans

A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.

26 Jun 2013

Primary care physicians prefer to prescribe NSAIDS for chronic pain, report shows

For treating the estimated 100 million Americans with chronic pain -- a population larger than those with heart disease, cancer and diabetes combined -- researched reported in The Journal of Pain shows that primary care physicians overwhelmingly prefer to prescribe non-steroidal anti-inflammatory medications, in accordance with published clinical practice guidelines.

26 Jun 2013

Tenet's acquisition of Vanguard Health part of plan to buy other hospitals

While news emerges regarding Tenet's plan to acqure Vanguard Health for $1.73 billion, the Ford Motor Co. announces its plans to launch a two-year health management program.

26 Jun 2013

Weill Cornell researchers discover high burden of hypertension in sub-Saharan African country

Based on the experience of a large hospital in Tanzania, Weill Cornell Medical College researchers have discovered a "startlingly" high burden of hypertension in this sub-Saharan African country.

26 Jun 2013

Vitamin D supplements lower blood pressure, improve moods in women with diabetes and depression

In women who have type 2 diabetes and show signs of depression, vitamin D supplements significantly lowered blood pressure and improved their moods, according to a pilot study at Loyola University Chicago Niehoff School of Nursing.

26 Jun 2013

AtheroNova starts AHRO-001 Phase 1 clinical trial for treatment of atherosclerosis

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers.

25 Jun 2013

First Edition: June 25, 2013

Today's headlines include reports about the Obama administraiton's plans for getting the word about the health law's online marketplaces.

25 Jun 2013

European study to evaluate CardioFocus' HeartLight Endoscopic Ablation System in AF patients

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation, announces that its HeartLight technology is the focus of a multicenter European clinical study for the treatment of drug-refractory persistent AF.

25 Jun 2013

Infinity announces data from IPI-145 Phase 1 study in patients with advanced hematologic malignancies

Infinity Pharmaceuticals, Inc. today announced Phase 1 data from an ongoing study of IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma in patients with advanced hematologic malignancies, or potentially fatal blood cancers.

25 Jun 2013

Does coffee influence appetite?

Can’t start the day without your coffee? Is that a bad thing? Studies have shown that coffee has a large number of protective health benefits, such as reducing the risks of diabetes, stroke, some forms of cancer, mental illness, and overall mortality. But how does it affect your appetite?

24 Jun 2013

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.

24 Jun 2013

New method allows assessment of direct stimulation effects on electric activity of human brain

Neuroscientists at the University of Tübingen have become the first to record neuromagnetic activity in the millisecond-by-millisecond range while the brain of a human subject was under stimulation by electric current. Electric brain stimulation has successfully been used in the treatment of neurological and psychiatric disorders for many decades.

24 Jun 2013

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that comprehensive data from a study of the company's PaQ Insulin Delivery Device will be presented today and tomorrow at the American Diabetes Association 73rd Scientific Sessions in Chicago, IL. The data suggest that PaQ can reduce known barriers to insulin therapy among people with type 2 diabetes, potentially improving their glycemic control.

24 Jun 2013

Chronic News and Research

Manchester researchers launch new project to better understand causes of RA

Ind., Ark. Medicaid expansion plans take shape, but also take time

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

BHS takes initiative to improve health and wellness of Berkshire community with CRI

Physician’s unfavorable attitudes about opioid drugs linked with lower rates of prescribing

Eisai submits BELVIQ NDS with Health Canada

Improving care for depression in low-income communities provides greater benefits: Study

Study explores analgesic activity of ceftriaxone in humans

Primary care physicians prefer to prescribe NSAIDS for chronic pain, report shows

Tenet's acquisition of Vanguard Health part of plan to buy other hospitals

Weill Cornell researchers discover high burden of hypertension in sub-Saharan African country

Vitamin D supplements lower blood pressure, improve moods in women with diabetes and depression

AtheroNova starts AHRO-001 Phase 1 clinical trial for treatment of atherosclerosis

First Edition: June 25, 2013

European study to evaluate CardioFocus' HeartLight Endoscopic Ablation System in AF patients

Infinity announces data from IPI-145 Phase 1 study in patients with advanced hematologic malignancies

Does coffee influence appetite?

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

New method allows assessment of direct stimulation effects on electric activity of human brain

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News